Thiodigalactoside inhibits murine cancers by concurrently blocking effects of galectin-1 on immune dysregulation, angiogenesis and protection against oxidative stress.
Journal Information
Full Title: Angiogenesis
Abbreviation: Angiogenesis
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"Conflict of interest No conflicts of interest by any of the authors."
Funding Disclosure
Evidence found in paper:
"The authors acknowledge Dr Ken Scott (University of Auckland, NZ) for contributing the mutant galectin-1 protein expression construct. We also thank Prof. R.K. Ralph, Dr Andy Wu and Dr Yuki Masuda for help in editing the manuscript and Dr Pauline Low and Dr Wendy Kelly for technical support. This study was supported by grant funding from the Cancer Council Queensland, Australia and from the Neumedix Health Group."
Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025